October 5, 2025/
Think of a new medicine as a new employee. For the first few years, you monitor them closely with frequent performance reviews. A PSUR/PBRER is like that comprehensive...
ALVigiLance is a dedicated pharmacovigilance platform designed to support the healthcare team in ensuring safer medication use. Our mission is simple yet vital: to provide trusted insights, practical tools, and up-to-date resources that empower healthcare professionals to identify, prevent, and manage adverse drug reactions (ADRs).
Simplified, practical guides on drug safety and monitoring.
Real-world examples to strengthen your clinical decision-making.
Summaries of global drug warnings and regulatory actions.
Strategies for adverse event reporting, risk management, and patient counseling.
To create a proactive community of healthcare providers who champion medication safety and improve patient outcomes through shared knowledge and vigilance.
Medication safety is everyone’s responsibility. Explore, learn, and engage with ALVigiLance — because together, we can reduce risks and save lives.
Think of a new medicine as a new employee. For the first few years, you monitor them closely with frequent performance reviews. A PSUR/PBRER is like that comprehensive...
The document "The use of the WHO-UMC system for standardised case causality assessment" provides a detailed explanation of the WHO-UMC causality assessment system, which is used in pharmacovigilance to...
The causality assessment of adverse events, to determine the relationship or connection between the drug and adverse events, is an essential and complex approach in pharmacovigilance....
